VORBEUGUNG ODER BEHANDLUNG VON HARNSÄURE- ODER GICHTERKRANKUNG

European patent · EP3251675 · In force

Register entry

Publication number
EP3251675
Application number
EP16742632
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Jan 28, 2016
Published
Dec 6, 2017
Granted
Apr 21, 2021
Protection ends at the latest
Jan 27, 2036
Next annual fee due
Jan 31, 2027
IPC classes
C07D 473/08 (2006.01)
C07D 473/06 (2006.01)
A61K 31/522 (2006.01)
A61P 13/04 (2006.01)
A61P 19/06 (2006.01)
A61P 29/00 (2006.01)
A61P 19/02 (2006.01)
A61P 13/12 (2006.01)
Priority
CN 201510048096 30.01.2015
CN 201510079809 13.02.2015
CN 201510080714 13.02.2015
CN 201510216089 30.04.2015
PCT application
PCT/CN2016/000061 28.01.2016
PCT publication
WO2016/119570 04.08.2016
Filing language
Chinese
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Oct 20, 2026

    Agent’s address changed

    Representative
    Dr. Lusuardi AG, Kreuzbühlstrasse 8, 8008 Zürich → Dr. Lusuardi AG, Stockerstrasse 8, 8002 Zürich

    Published in Swissreg on 20.10.2026

  2. Feb 1, 2026

    Next annual fee due on

    Next annual fee due on
    31.01.2026 → 31.01.2027

    Published in Swissreg on 01.02.2026

  3. Jan 29, 2026

    Holder’s address changed

    Owner
    Shanton Pharma Pte. Ltd., 80 Robinson Road 02-00, Singapore 068898, Singapore → Shanton Pharma Pte. Ltd., 168 Robinson Road, # 13-05, Capital Tower, Singapore 068912, Singapore

    Published in Swissreg on 29.01.2026

  4. Feb 1, 2025

    Next annual fee due on

    Next annual fee due on
    31.01.2025 → 31.01.2026

    Published in Swissreg on 01.02.2025

  5. Feb 1, 2024

    Change

    Published in Swissreg on 01.02.2024

  6. Feb 1, 2023

    Change

    Published in Swissreg on 01.02.2023

  7. Mar 2, 2022

    Change

    Published in Swissreg on 02.03.2022

  8. Jun 5, 2021

    Agent entered

    Representative
    Dr. Lusuardi AG, Kreuzbühlstrasse 8, 8008 Zürich

    Published in Swissreg on 05.06.2021

1 earlier entry
  1. Apr 21, 2021

    Granted

    Published in Swissreg on 21.04.2021

Parties

Holder

Shanton Pharma Pte. Ltd.

168 Robinson Road, # 13-05 Capital Tower, Singapore 068912, SG

Agent

Dr. Lusuardi AG

Stockerstrasse 8, 8002 Zürich

Inventor

LIU, Jinrong

Jinan Shandong 250101, CN

HUANG, Zhenhua

Jinan Shandong 250101, CN

ZHANG, Qian

Jinan Shandong 250101, CN

CHI, Shuangshuang

Jinan Shandong 250101, CN

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.